This inaugural event will bring together a number of key professionals to examine the optimal strategies to effectively standardise and manage your clinical data. This is a unique opportunity to hear how implementing CDISC standards have actually impacted on pharmaceutical and biotech companies such as AstraZeneca, Roche, Bayer and Genzyme.
The unparalleled programme includes Senior Level Speakers from AstraZeneca, Bayer, GlaxoSmithKline, Roche, Boehringer-Ingelheim, Novo Nordisk and many more.
The unparalleled programme includes Senior Level Speakers from AstraZeneca, Bayer, GlaxoSmithKline, Roche, Boehringer-Ingelheim, Novo Nordisk and many more.
